Vancomycin-resistant enterococci (VRE): transmission and control
- PMID: 18164908
- DOI: 10.1016/j.ijantimicag.2007.08.026
Vancomycin-resistant enterococci (VRE): transmission and control
Abstract
Transmission of vancomycin-resistant enterococci (VRE) can occur through direct contact with colonised or infected patients or through indirect contact via the hands of health-care workers (HCWs), or via contaminated patient care equipment or environmental surfaces. Antibiotic exposure plays an important role in the transmission dynamic of VRE. Until now, the control measures aimed at reducing the incidence of VRE colonisation and infection in hospitals have included: education of HCWs with implementation of hand-washing practices and compliance; wide and targeted surveillance cultures; isolation of VRE-positive patients; pre-emptive isolation of high-risk patients; and restriction of antibiotic use. However, despite these, VRE is still endemic in many hospitals. The causes of this could be non-compliance with infection control interventions, overuse of antibiotics, and insensitive microbiological methods for detecting VRE in stool. A scoring system using point values has been demonstrated to be useful in reducing rates of nosocomial VRE colonisation. Future prospective comparative studies of infection control approaches in different epidemiological situations might be useful.
Similar articles
-
Transfer of vancomycin-resistant enterococci via health care worker hands.Arch Intern Med. 2005 Feb 14;165(3):302-7. doi: 10.1001/archinte.165.3.302. Arch Intern Med. 2005. PMID: 15710793
-
Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.Intern Med J. 2004 Aug;34(8):510-2. doi: 10.1111/j.1444-0903.2004.00666.x. Intern Med J. 2004. PMID: 15317552
-
Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.Clin Infect Dis. 2008 Mar 1;46(5):678-85. doi: 10.1086/527394. Clin Infect Dis. 2008. PMID: 18230044
-
Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.Clin Infect Dis. 2000 Oct;31(4):1058-65. doi: 10.1086/318126. Epub 2000 Oct 25. Clin Infect Dis. 2000. PMID: 11049790 Review.
-
Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker.Can Oper Room Nurs J. 2008 Mar;26(1):21-4, 26-9, 32. Can Oper Room Nurs J. 2008. PMID: 18444472 Review.
Cited by
-
Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.J Korean Med Sci. 2015 Jun;30(6):688-93. doi: 10.3346/jkms.2015.30.6.688. Epub 2015 May 13. J Korean Med Sci. 2015. PMID: 26028918 Free PMC article. Clinical Trial.
-
Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.J Korean Neurosurg Soc. 2009 Aug;46(2):123-9. doi: 10.3340/jkns.2009.46.2.123. Epub 2009 Aug 31. J Korean Neurosurg Soc. 2009. PMID: 19763214 Free PMC article.
-
Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship Programs.Infect Dis Rep. 2017 Mar 30;9(1):6839. doi: 10.4081/idr.2017.6839. eCollection 2017 Mar 30. Infect Dis Rep. 2017. PMID: 28458798 Free PMC article. Review.
-
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity.Bioorg Med Chem Lett. 2011 Aug 15;21(16):4720-3. doi: 10.1016/j.bmcl.2011.06.081. Epub 2011 Jun 25. Bioorg Med Chem Lett. 2011. PMID: 21752646 Free PMC article.
-
Genome-Wide Mutagenesis Identifies Factors Involved in Enterococcus faecalis Vaginal Adherence and Persistence.Infect Immun. 2020 Sep 18;88(10):e00270-20. doi: 10.1128/IAI.00270-20. Print 2020 Sep 18. Infect Immun. 2020. PMID: 32778611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources